OncNGS
  • Home
  • Call for tenders (closed)
  • About OncNGS
  • Phases
    • Pre-commercial Procedure
    • Phase 0 : Curiosity Driven Research
    • Open Market Consultation
    • Phase I : Solution design
    • Phase II: Prototype development
    • Phase III : Clinical validation of a limited set of pre-commercial devices
  • FAQ
  • News
  • Contact
  • Workspace
  • Home
  • Call for tenders (closed)
  • About OncNGS
  • Phases
    • Pre-commercial Procedure
    • Phase 0 : Curiosity Driven Research
    • Open Market Consultation
    • Phase I : Solution design
    • Phase II: Prototype development
    • Phase III : Clinical validation of a limited set of pre-commercial devices
  • FAQ
  • News
  • Contact
  • Workspace

Pre-commercial Procedure

The pre-commercial procurement procedure consists of three clearly defined phases: Solution design, Prototype development and Clinical validation of a limited scale pre-commercial devices (see graphic below).

Phase 1 – Solution design:  concepts elaboration into the competitive solutions. Minimum 4 designs will be selected.

Phase 2 – Prototype development:  development of the well outlined and functioning prototypes. Minimum 3 designs will be selected.

Phase 3 – Clinical validation of a limited scale pre-commercial devices:  the functional and technical properties of the selected solutions will be evaluated in an operational environment. Minimum of 2 pre-commercial devices will be deployed.

Phases of OncNGS PCP
Contact us

Other phases

Phase 0 : Curiosity Driven Research
Phase I : Solution design
Phase II: Prototype development
Phase III : Clinical validation of a limited set of pre-commercial devices / Clinical testing

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874467

Follow us:

© OncNGS

  • Privacy policy
  • Disclaimer